267 related articles for article (PubMed ID: 16334163)
21. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa.
Ogden GR; Kiddie RA; Lunny DP; Lane DP
J Pathol; 1992 Apr; 166(4):389-94. PubMed ID: 1381431
[TBL] [Abstract][Full Text] [Related]
22. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
24. [Expressions of p-MAPK, cyclin D1, p53 protein and their relationship in osteosarcoma].
Hu JZ; Feng DY; Cheng RX
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):325-7. PubMed ID: 12536724
[TBL] [Abstract][Full Text] [Related]
25. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
26. Cyclin alterations in giant cell tumor of bone.
Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
[TBL] [Abstract][Full Text] [Related]
27. Assessment of laminin-5 in oral dysplasia and squamous cell carcinoma.
Rani V; McCullough M; Chandu A
J Oral Maxillofac Surg; 2013 Nov; 71(11):1873-9. PubMed ID: 23891017
[TBL] [Abstract][Full Text] [Related]
28. Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias.
Takeda T; Sugihara K; Hirayama Y; Hirano M; Tanuma JI; Semba I
J Oral Pathol Med; 2006 Jul; 35(6):369-75. PubMed ID: 16762018
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
30. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa.
Liu SC; Hu Y; Sauter ER; Clapper ML; Chen SY; Lanfranchi HE; Engstrom PF; Klein-Szanto AJ
Anal Quant Cytol Histol; 1999 Apr; 21(2):166-73. PubMed ID: 10560487
[TBL] [Abstract][Full Text] [Related]
31. [Immunohistochemical analysis of cell cycle-associated proteins p27 in oral cancer and precancer].
Hou B; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Feb; 41(2):102-5. PubMed ID: 16640935
[TBL] [Abstract][Full Text] [Related]
32. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer.
Pastuszewski W; Dziegiel P; Krecicki T; Podhorska-Okolow M; Ciesielska U; Gorzynska E; Zabel M
Anticancer Res; 2007; 27(1A):335-42. PubMed ID: 17352251
[TBL] [Abstract][Full Text] [Related]
34. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
Acay RR; Felizzola CR; de Araújo N; de Sousa SO
Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
[TBL] [Abstract][Full Text] [Related]
36. Laminin-5 gamma 2: a marker to identify oral mucosal lesions at risk for tumor development?
Nordemar S; Högmo A; Lindholm J; Auer G; Munck-Wikland E
Anticancer Res; 2003; 23(6D):4985-9. PubMed ID: 14981956
[TBL] [Abstract][Full Text] [Related]
37. Possible prognostic significance of p53, cyclin D1 and Ki-67 in the second primary malignancy of patients with double primary malignancies.
Dong M; Wei H; Hou JM; Gao S; Yang DZ; Lin ZH; Jia Y; Ren XP; Gao MH
Int J Clin Exp Pathol; 2014; 7(7):3975-83. PubMed ID: 25120774
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions.
Hamadah O; Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2010 Oct; 48(7):503-6. PubMed ID: 19800717
[TBL] [Abstract][Full Text] [Related]
39. Expression of apoptotic and cell proliferation regulatory proteins in actinic cheilitis.
Martínez A; Brethauer U; Rojas IG; Spencer M; Mucientes F; Borlando J; Rudolph MI
J Oral Pathol Med; 2005 May; 34(5):257-62. PubMed ID: 15817067
[TBL] [Abstract][Full Text] [Related]
40. [Immunohistochemical study of benign lymphoadenosis of oral mucosa].
Li SX; Yu SF; Sun KH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]